As global health systems face growing pressure from rising costs, aging populations, and widening access gaps, a new paradigm is emerging—one that centers prevention, equity, and bold cross-sector collaboration. In this plenary session, we’ll hear from leading voices at the World Health Organization, the Finnish Ministry of Social Affairs and Health, and Merck KGaA, who are each reimagining how to design and fund health systems for long-term impact. 

From Finland’s bold ambition to become the first country that spends more on prevention than on treatment, to the WHO’s work advancing public–private partnerships that drive systemic change, to Merck’s efforts to embed health equity across its innovation and commercial strategies, this conversation will challenge long-held assumptions about how value is defined—and who it serves. Join us to explore how visionary policy, data-driven investment, and industry leadership can work together to shift the trajectory of health equity on a global scale. 

Speakers 

Kristin Shanley Milburn 

SVP, Marketing Ecosystem & Strategy, EVERSANA 

Moredreck Chibi 

Public Health Innovation Lead, World Health Organization | Regional Office for Europe 

Chrys Herrera 

Head of Health Equity and Access Realization, Merck KGaA 

Päivi Sillanaukee 

Special Envoy for Health and Wellbeing, Ministry of Social Affairs and Health (MSAH)